Purpose
to conjugate a fusion of three highly-conserved pneumococcal antigens to the already approved Vi polysaccharide vaccine used for typhus. Then test the vaccine's ability to induce strong immune responses against pneumococcus and typhoid fever.
Grantee
Division
Global Health
Date
NOVEMBER 2009
Region served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
18
Grantee location
Boston, Massachusetts, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.